This trial is active, not recruiting.

Conditions in-hospital mortality, number of icu readmission, number of warnings on-duty
Treatment none intervention
Sponsor Althaia Xarxa Assistencial Universitària de Manresa
Start date October 2015
End date September 2016
Trial size 1200 participants
Trial identifier NCT02599636, Althaia


Many factors before and after ICU stay determine the outcome of patients at ICU discharge, the type of illness, physical dependence and other sequelae can be a trigger for complications in hospital ward which can induce ICU readmission and worse outcome. The quality of medical assistance during all the hospitalisation should be guaranteed and many complications or fatal events could be avoidable.

The objective of the present study is to demonstrate that collaboration between the intensivist and other medical teams in ward can reduce ICU readmission and hospital mortality after ICU discharge.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

The decline in hospital mortality
time frame: 3 months

Secondary Outcomes

The decline in number of warnings on-duty
time frame: 3 months

Eligibility Criteria

Male or female participants from 18 years up to 99 years old.

Inclusion Criteria: - All patients with Sabadell Score 1 (poor prognosis in long term) and 2 (poor prognosis in short term) at ICU discharge Exclusion Criteria: - patients younger than 18 years old - patients with Sabadell Score 0 (good prognosis) - patients with Sabadell Score 3 (null expected survival) - patients transferred to other hospitals

Additional Information

Official title Multicenter Prospective Study: To Survive After ICU Discharge
Principal investigator Silvia Cano Hernández, Physician
Description Material and Methods This observational multicenter study will be done in 21 medical-surgical ICUs. We will use Sabadell Score like prognostic scale at ICU discharge and the intensivist will collaborate with the medical team in medical assistance of patients at risk (Sabadell Score 1 and 2). Investigators will compare the hospital mortality and the readmission rate with a previous period when this collaboration didn't exist. Anticipate results The collaboration of attending intensivist might reduce ward mortality after ICU discharge by 3%.
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by Althaia Xarxa Assistencial Universitària de Manresa.